Your browser doesn't support javascript.
loading
Challenges, progress, and opportunities: proceedings of the filovirus medical countermeasures workshop.
Hirschberg, Rona; Ward, Lucy A; Kilgore, Nicole; Kurnat, Rebecca; Schiltz, Helen; Albrecht, Mark T; Christopher, George W; Nuzum, Ed.
Afiliação
  • Hirschberg R; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Rona.Hirschberg@verizon.net.
  • Ward LA; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. lward@niaid.nih.gov.
  • Kilgore N; Medical Countermeasure Systems, Department of Defense, Ft. Detrick, Frederick, MD 21702, USA. nicole.r.kilgore.civ@mail.mil.
  • Kurnat R; Medical Countermeasure Systems, Department of Defense, Ft. Detrick, Frederick, MD 21702, USA. rebecca.kurnat.civ@mail.mil.
  • Schiltz H; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. hschiltz@niaid.nih.gov.
  • Albrecht MT; Biodefense Advanced Research and Development Authority, Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC 20201, USA. mark.albrecht@hhs.gov.
  • Christopher GW; Medical Countermeasure Systems, Department of Defense, Fort Belvoir, VA 22060, USA. george.w.christopher.civ@mail.mil.
  • Nuzum E; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. enuzum@niaid.nih.gov.
Viruses ; 6(7): 2673-97, 2014 Jul 09.
Article em En | MEDLINE | ID: mdl-25010768
ABSTRACT
On August 22-23, 2013, agencies within the United States Department of Defense (DoD) and the Department of Health and Human Services (HHS) sponsored the Filovirus Medical Countermeasures (MCMs) Workshop as an extension of the activities of the Filovirus Animal Non-clinical Group (FANG). The FANG is a federally-recognized multi-Agency group established in 2011 to coordinate and facilitate U.S. government (USG) efforts to develop filovirus MCMs. The workshop brought together government, academic and industry experts to consider the needs for filovirus MCMs and evaluate the status of the product development pipeline. This report summarizes speaker presentations and highlights progress and challenges remaining in the field.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Filoviridae / Infecções por Filoviridae / Anticorpos Antivirais Limite: Animals / Humans País/Região como assunto: America do norte Idioma: En Revista: Viruses Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: CH / SUIZA / SUÍÇA / SWITZERLAND
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Filoviridae / Infecções por Filoviridae / Anticorpos Antivirais Limite: Animals / Humans País/Região como assunto: America do norte Idioma: En Revista: Viruses Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: CH / SUIZA / SUÍÇA / SWITZERLAND